Palleon Pharmaceuticals

Pre-clinical

Waltham, United StatesFounded 2015palleonpharma.com

Focuses on developing immunotherapies targeting glyco-immune checkpoints for cancer treatment.

Market Cap

Private

Pipeline

—

Patents

—

Publications

—

Private Company

Total funding raised: $232M

Focuses on developing immunotherapies targeting glyco-immune checkpoints for cancer treatment.

AntibodiesBiologics

Total raised:$232M

Series B$132MSurveyor CapitalJan 15, 2022

Series A$100MMPM CapitalMay 15, 2020